The North America Lab Automation Market size was valued at USD 5,240 Million in 2025 and is expected to reach USD 13,800 Million at a CAGR of 9.1% from 2024 to 2035.
The economic impact of tariffs on "North America Lab Automation Market".
Market Growth Drivers
Increased Adoption of Robotics in Clinical Diagnostics: The heightened demand for efficient and precise laboratory operations has led to the widespread adoption of robotics and automation systems. Major players like Thermo Fisher Scientific are investing in advanced lab automation platforms that enhance productivity, reduce errors, and enable high-throughput screening, particularly in clinical diagnostics and genomics workflows. These technologies streamline routine tasks such as sample preparation and liquid handling, cutting down operational costs and turnaround times. The adoption trend is expected to continue as hospitals and clinical labs prioritize automation to meet increasing case volumes and improve patient outcomes.
Rising Investments in Life Sciences Research: With the surge in pharmaceutical R&D, especially in drug discovery and development, automation technologies have become essential for increasing throughput and efficiency. Companies like Beckman Coulter are collaborating with research institutes and pharmaceutical firms to deploy advanced laboratory workflow solutions. Enhanced automation supports complex experiments, such as next-generation sequencing and cell-based assays, driving faster and more reproducible scientific insights. This uplift in life sciences investment is powering the demand for sophisticated lab automation systems across North America.
Market Trends
Integration of Artificial Intelligence (AI) with Lab Automation: AI integration is revolutionizing lab automation by enabling real-time data processing, predictive analytics, and self-optimizing workflows. Companies such as PerkinElmer are launching AI-powered automation platforms that enhance decision-making for laboratory professionals, helping to minimize manual interventions and accelerate discovery cycles. This trend is transforming laboratory operations by delivering higher accuracy, smarter sample management, and enabling labs to handle increasingly complex data landscapes.
Expansion of Remote and Cloud-based Laboratory Solutions: Remote lab management and cloud connectivity are becoming mainstream, empowering laboratories to monitor operations and analyze results from any location. Hamilton Company has been at the forefront, offering scalable automation solutions integrated with remote management capabilities. The COVID-19 pandemic further accelerated adoption, as distributed teams required access to real-time data and remote troubleshooting. This trend is expected to persist, supporting decentralized research and collaborative projects across North America.
Market Opportunities
Growth in Personalized Medicine: The increasing shift towards personalized medicine in North America creates an opportunity for lab automation to support high-throughput genomic and proteomic workflows, enabling faster and more accurate diagnostics. Companies like Agilent Technologies are poised to benefit by providing automation systems tailored to these advanced applications.
Expansion into Small and Mid-sized Laboratories: There is significant growth potential in targeting small and medium-sized labs with affordable and modular automation solutions. Firms such as Tecan Group are offering scalable products that lower the entry barrier for automation adoption in these underserved segments.
North America Lab Automation Market Revenue (2020-2035)
The chart depicts a steady and robust growth trajectory in the North America Lab Automation Market from 2020 to 2035. Starting at USD 2,950 million in 2020, the market shows gradual increments through the decade, accelerating after 2025 as advanced automation and AI-driven solutions gain wider acceptance. By 2030, revenue reaches USD 8,900 million, and with continued investments in healthcare digitization and life sciences research, the market is projected to hit USD 13,800 million by 2035. This growth reflects the increasing reliance on laboratory automation for improved efficiency, accuracy, and competitiveness across both clinical and research laboratories.
Market Share by Region, 2025
The pie chart illustrates the distribution of market share among key regions in North America for 2025. The United States dominates the lab automation market with 77% share, attributed to high healthcare spending, rapid adoption of automation, and the presence of leading market players. Canada accounts for 14% as it accelerates healthcare infrastructure investments and R&D, while Mexico holds an 8% share, driven by the growth of pharmaceutical manufacturing. The 'Rest of North America' segment, covering smaller countries and territories, represents a 1% share. The significant market concentration in the U.S. is expected to continue, although regional adoption rates may increase in Canada and Mexico over the forecast period.
Recent Developments in North America Lab Automation Market
In May 2024, Thermo Fisher Scientific launched its new 'Momentum 3.0' lab automation software suite targeting high-throughput applications in pharmaceutical and clinical diagnostics laboratories. The suite features enhanced AI-driven process optimization and IoT connectivity, facilitating seamless data integration and remote device management. The product has already been adopted by several reference labs, setting new standards for workflow efficiency and supporting regulatory compliance efforts.
In March 2024, Beckman Coulter announced a strategic partnership with GenScript Biotech to develop automated platforms for genomic sample processing. The initiative focuses on improving workflow automation in cancer research and precision medicine, combining Beckman’s automated workstations with GenScript’s advanced assay kits. This collaboration is aimed at reducing sample processing time while improving accuracy and scalability, particularly across major research centers in the U.S. and Canada.
In February 2024, Hamilton Company unveiled a compact and modular robotic liquid handling system designed for small and mid-sized labs. The system, launched as the 'Microlab Aurora MINI', features cloud-based remote monitoring, flexible deck layouts, and scalable throughput. Early adopters have reported reductions in manual labor hours by up to 40% and enhanced reproducibility of lab results. The product underlines Hamilton’s commitment to broadening automation accessibility in North America.
Press Releases